IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 31 filers reported holding IMMUCELL CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,698 | +13.8% | 12,865 | +6.5% | 0.00% | – |
| Q2 2023 | $60,385 | -4.8% | 12,077 | -2.7% | 0.00% | – |
| Q1 2023 | $63,445 | -16.4% | 12,416 | -0.2% | 0.00% | – |
| Q4 2022 | $75,914 | -20.1% | 12,445 | -1.8% | 0.00% | – |
| Q3 2022 | $95,000 | -13.6% | 12,667 | +0.3% | 0.00% | – |
| Q2 2022 | $110,000 | -14.1% | 12,633 | -5.2% | 0.00% | – |
| Q1 2022 | $128,000 | +20.8% | 13,325 | +0.4% | 0.00% | – |
| Q4 2021 | $106,000 | -16.5% | 13,275 | -1.7% | 0.00% | – |
| Q3 2021 | $127,000 | -0.8% | 13,503 | +0.3% | 0.00% | – |
| Q2 2021 | $128,000 | -1.5% | 13,465 | 0.0% | 0.00% | – |
| Q1 2021 | $130,000 | +71.1% | 13,465 | +4.7% | 0.00% | – |
| Q4 2020 | $76,000 | +20.6% | 12,865 | +11.0% | 0.00% | – |
| Q3 2020 | $63,000 | 0.0% | 11,594 | -13.6% | 0.00% | – |
| Q2 2020 | $63,000 | +28.6% | 13,413 | +3.4% | 0.00% | – |
| Q1 2020 | $49,000 | -43.7% | 12,966 | +24.2% | 0.00% | – |
| Q3 2018 | $87,000 | +22.5% | 10,443 | 0.0% | 0.00% | – |
| Q2 2018 | $71,000 | – | 10,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERRITT CAPITAL MANAGEMENT INC | 153,000 | $972,000 | 0.36% |
| Antara Capital LP | 105,000 | $666,000 | 0.19% |
| HEARTLAND ADVISORS INC | 199,600 | $1,267,000 | 0.09% |
| CVI Holdings, LLC | 10,000 | $64,000 | 0.06% |
| Minerva Advisors LLC | 14,559 | $93,000 | 0.05% |
| WEXFORD CAPITAL LP | 90,000 | $572,000 | 0.05% |
| Essex Financial Services, Inc. | 21,000 | $133,000 | 0.04% |
| SHUFRO ROSE & CO LLC | 50,670 | $322,000 | 0.03% |
| INGALLS & SNYDER LLC | 91,511 | $581,000 | 0.03% |
| HM PAYSON & CO | 51,500 | $327,000 | 0.01% |